Serum Institute's Covovax approved for kids aged 7 to 11 years

Gallery

MORE...

Sports

Men’s Sr Hockey Nationals to be played in division-based format from April 4

The 15th Hockey India Senior Men National Championship, set to take place from April 4 to

Mensik denies Djokovic 100th title in Miami final

KIPG: Son of a vegetable vendor, Bihar’s Jhandu Kumar eyes Worlds, 2028 Paralympics

Hardik Singh credits hard work and team unity for receiving HI Midfielder of the Year award

Djokovic, Alcaraz land in same half of Miami draw

India to host 2nd Asian Yogasana Championships from March 29 to 31

MORE...

Serum Institute's Covovax approved for kids aged 7 to 11 years

Last Updated : 28 Jun 2022 11:12:40 PM IST

India's apex drugs regulator, the Drugs Controller General of India (DCGI), on Tuesday approved Pune-based Serum Institute's Covid vaccine Covovax for children aged 7 to 11 years, as per a source.

The source said that SII's Covovax vaccine has been approved for restricted emergency use in children aged 7 to 11 years subject with certain conditions.

On June 24, the DCGI's Subject Expert Committee had recommended emergency use authorisation to Covovax vaccine for use in children aged 7-11.

As per the source, the DCGI has also approved India's first indigenously developed mRNA vaccine against Covid-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above.

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group, subject to certain conditions, on March 9.